7-octadecynoic acid

7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid

MeSH term MeSH ID Detail
Uremia D014511 33 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Diarrhea D003967 32 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Neoplasms, Experimental D009374 10 associated lipids
Hypercalcemia D006934 13 associated lipids
Neovascularization, Pathologic D009389 39 associated lipids
Adenocarcinoma D000230 166 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Lung Neoplasms D008175 171 associated lipids
Wounds and Injuries D014947 20 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Inflammation D007249 119 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Diabetes Mellitus, Type 1 D003922 56 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Diabetic Nephropathies D003928 39 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Body Weight D001835 333 associated lipids
Per page 10 20 50 100 | Total 298

All references with 7-octadecynoic acid

Download all related citations
Per page 10 20 50 100 | Total 4091
Authors Title Published Journal PubMed Link
Kwon A et al. Serum Osteoprotegerin Is Associated With Calcified Carotid Plaque: A Strobe-Compliant Observational Study. 2016 Medicine (Baltimore) pmid:27082605
Gautam J et al. An isoflavone cladrin prevents high-fat diet-induced bone loss and inhibits the expression of adipogenic gene regulators in 3T3-L1 adipocyte. 2016 J. Pharm. Pharmacol. pmid:27265669
Maser RE et al. Osteopontin and osteoprotegerin levels in type 2 diabetes and their association with cardiovascular autonomic function. 2016 J. Diabetes Complicat. pmid:26775555
Gottesman GS et al. Auricular ossification: A newly recognized feature of osteoprotegerin-deficiency juvenile Paget disease. 2016 Am. J. Med. Genet. A pmid:26762549
Totoson P et al. Endothelial Dysfunction in Rheumatoid Arthritis: Mechanistic Insights and Correlation with Circulating Markers of Systemic Inflammation. 2016 PLoS ONE pmid:26761790
Kuroda Y et al. Osteoprotegerin Regulates Pancreatic β-Cell Homeostasis upon Microbial Invasion. 2016 PLoS ONE pmid:26751951
Bougioukli S et al. Combination therapy with BMP-2 and a systemic RANKL inhibitor enhances bone healing in a mouse critical-sized femoral defect. 2016 Bone pmid:26723577
Kobayashi Y et al. Regulation of bone metabolism by Wnt signals. 2016 J. Biochem. pmid:26711238
Iezaki T et al. The Transcriptional Modulator Interferon-Related Developmental Regulator 1 in Osteoblasts Suppresses Bone Formation and Promotes Bone Resorption. 2016 J. Bone Miner. Res. pmid:26391411
Meijome TE et al. C-Mpl Is Expressed on Osteoblasts and Osteoclasts and Is Important in Regulating Skeletal Homeostasis. 2016 J. Cell. Biochem. pmid:26375403
Kim CS et al. Association of Serum Osteoprotegerin Levels with Bone Loss in Chronic Kidney Disease: Insights from the KNOW-CKD Study. 2016 PLoS ONE pmid:27855207
Li XJ et al. Bergapten exerts inhibitory effects on diabetes-related osteoporosis via the regulation of the PI3K/AKT, JNK/MAPK and NF-κB signaling pathways in osteoprotegerin knockout mice. 2016 Int. J. Mol. Med. pmid:27840967
Zhou J and Zhao Y Osteoprotegerin Gene (OPG) Polymorphisms Associated with Peri-implantitis Susceptibility in a Chinese Han Population. 2016 Med. Sci. Monit. pmid:27828936
Ostrowska Z et al. TGF-β1, bone metabolism, osteoprotegerin, and soluble receptor activator of nuclear factor-kB ligand in girls with anorexia nervosa. 2016 Endokrynol Pol pmid:27828689
Kan C et al. Cancer Cell Colonisation in the Bone Microenvironment. 2016 Int J Mol Sci pmid:27782035
Huang HM et al. Effects of Roughly Focused Extracorporeal Shock Waves Therapy on the Expressions of Bone Morphogenetic Protein-2 and Osteoprotegerin in Osteoporotic Fracture in Rats. 2016 Chin. Med. J. pmid:27779163
Bernardi S et al. Roles and Clinical Applications of OPG and TRAIL as Biomarkers in Cardiovascular Disease. 2016 Biomed Res Int pmid:27200369
Wei CC et al. Icariin Prevents Cartilage and Bone Degradation in Experimental Models of Arthritis. 2016 Mediators Inflamm. pmid:27199510
Usategui-Martín R et al. VAV3 Gene Polymorphism Is Associated with Paget's Disease of Bone. 2016 Genet Test Mol Biomarkers pmid:27172236
Li B et al. Unfractionated Heparin Promotes Osteoclast Formation in Vitro by Inhibiting Osteoprotegerin Activity. 2016 Int J Mol Sci pmid:27110777

Table of Content